FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 260 filers reported holding FATE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $10,879,000 | +1019.2% | 125,350 | +962.7% | 1.35% | +977.6% |
| Q1 2021 | $972,000 | +196.3% | 11,795 | -20.2% | 0.12% | +15.7% |
| Q1 2020 | $328,000 | -83.1% | 14,780 | -88.2% | 0.11% | -82.9% |
| Q3 2019 | $1,942,000 | +55.2% | 125,060 | +103.0% | 0.63% | +55.5% |
| Q2 2019 | $1,251,000 | -60.2% | 61,615 | -65.5% | 0.41% | -63.4% |
| Q1 2019 | $3,141,000 | +71.5% | 178,790 | +25.2% | 1.11% | +50.4% |
| Q4 2018 | $1,832,000 | – | 142,760 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
| Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
| Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
| Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
| GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
| Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
| Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
| Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
| XTX Topco Ltd | 192,920 | $408,990 | 0.07% |